Leslie Williams joined the Board of Directors in 2019. She has more than 25 years of industry experience in healthcare, management, commercial product development and marketing. In 2010 she founded ImmusanT, Inc., which subsequently acquired the assets of Melbourne, Australia based Nexpep. Prior to founding ImmusanT, she was President & CEO of Ventaira Pharmaceuticals, a significant player in the pulmonary drug delivery market. Ms. Williams’ prior pharmaceutical industry experience includes commercial positions at INO Therapeutics, Merck and GlaxoSmithKline, and drug-delivery and -monitoring experience at Datex-Ohmeda (formerly Ohmeda, Inc.). She was a venture partner at Battelle Ventures and served on the Boards of Hepregen Corporation, CDI Bioscience, and on the Board of The Capital Network (TCN). She currently serves on the Advisory Board of Life Science Cares and is on the Executive Board of the University of Iowa School of Pharmacy. She also serves on the Editorial Advisory Board of Life Science Leader as well as The Journal of Advanced Therapies and Medical Innovation Sciences. Ms. Williams holds an MBA from Washington University, John Olin School of Business, and a BS degree with honors in nursing from the University of Iowa. Before entering industry, she was a critical-care nurse at Duke University, Medical College of Virginia and at the University of Iowa.